Systematic ReviewResearch

PRES in eclampsia or pre-eclampsia was associated with higher liver enzymes and lower platelets

Neurological sciences (PubMed)Sep 10, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

A systematic review and meta-analysis of patients with eclampsia or pre-eclampsia found that PRES was associated with higher alanine and aspartate aminotransferase levels, lower platelet counts, and higher total bilirubin, but the underlying evidence was highly heterogeneous.

What NurseJet pulled from the source

Across 28 studies, the pooled PRES incidence was 38.68%, but heterogeneity was very high (I²=98.5%). Maternal mortality was numerically higher with PRES but not statistically significant, and stillbirth and preterm birth were not significantly associated.

Why this matters for nurses

PRES is a serious neurologic complication in hypertensive pregnancy disorders; the review highlights associated laboratory and imaging patterns without establishing a diagnostic rule.

Bedside takeaway

Treat laboratory patterns as supportive context, not a diagnostic rule, and escalate neurologic change under local protocol.

Key takeaways

Compared with patients without PRES, mean alanine aminotransferase was 35.88 IU/L higher, mean aspartate aminotransferase was 48.69 IU/L higher, and mean platelet count was 31.15×10⁹/L lower.
The pooled imaging findings most often involved the frontal and temporal lobes.
The authors called for higher-quality prospective studies and standardized prediction models before these factors are used predictively.

Practice implications

Escalate new neurologic changes promptly and trend ordered blood pressure and laboratory assessments within the local pre-eclampsia and eclampsia protocol.

Limitations & cautions

Abstract-only summary. The 28 studies were highly heterogeneous, association does not establish prediction or causation, and the pooled incidence may not generalize across settings or patient severity.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Open source

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

Neurological sciences (PubMed)

Neurological sciences (PubMed). Clinical, Laboratory and Radiological Factors associated with posterior reversible encephalopathy syndrome (PRES) in patients with eclampsia or pre-eclampsia: a systematic review and meta-analysis.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42717136/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

BMJ open diabetes research & care (PubMed)Sep 9, 2026Systematic Review

A systematic review of randomized trials found statistically improved glycemic measures with diabetes-specific rather than standard tube-feeding formulas in critically ill and long-term-care patients with hyperglycemia, although most evidence was limited by small effects, imprecision, or heterogeneity.

ICU GeriatricsAI summaryReview source

Systematic ReviewResearchMedication SafetyAI summary · original source linked below

Five critical-care trials randomized 483 patients and three long-term-care trials randomized 137. In critical care, mean glucose was 0.54 mmol/L lower with diabetes-specific formulas; in long-term care, hemoglobin A1c was 0.92 percentage points lower, with low certainty for the latter result.

Key takeaways

Critical-care trials also found lower glucose variability, but those estimates had substantial heterogeneity and low certainty.
The mean-glucose estimate in critical care had moderate certainty and low statistical heterogeneity.
Evidence for outcomes beyond glycemic measures was uncertain because of limited reporting, inconsistent findings, and small samples.

Why this matters on shift

Formula choice may affect glucose management during enteral feeding, but the review does not establish broader clinical-outcome benefits.

Bedside takeaway

Use glucose trends and feeding delivery data to inform team decisions; do not assume formula changes improve outcomes beyond glycemia.

Nursing implications

Track glucose trends, feed delivery and interruptions, and tolerance, then coordinate formula or insulin concerns with the prescribing and nutrition teams.

Limitations & cautions

Abstract-only summary. The evidence comprised eight trials and 620 patients across two different care settings; several estimates were imprecise or highly heterogeneous, and broader clinical outcomes remained uncertain.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

BMJ open diabetes research & care (PubMed). Diabetes-specific nutritional formulas for tube feeding in patients with hyperglycemia: a systematic review and meta-analysis.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Pediatric quality & safety (PubMed)Sep 9, 2026Research Article

A pediatric hospital quality-improvement project that added a CLABSI watcher program, central-line nurses, proactive huddles, and standardized escalation processes was associated with sustained reductions in central line-associated bloodstream infection rates.

Peds Med-SurgAI summaryReview source

Research ArticleQuality ImprovementInfection ControlWorkflowAI summary · original source linked below

The baseline process mean was 0.97 CLABSIs per 1,000 central-line days. It shifted to 0.13 beginning in June 2021, and a second shift to 0.00 occurred from August 2023 through December 2024; the rate through December 2023 was 65% lower at 0.34 per 1,000 line days.

Key takeaways

An earlier cause analysis identified failure to escalate central-line concerns as a potential improvement target.
The program paired existing insertion and maintenance bundles with proactive risk assessment, nurse-led coordination, and standardized escalation.
Statistical process-control charts identified two downward shifts in the hospital-wide CLABSI process mean.

Why this matters on shift

The report suggests that reliable escalation and team communication may add value when infections persist despite established central-line insertion and maintenance practices.

Bedside takeaway

Escalate central-line concerns early while continuing the full local insertion and maintenance bundle.

Nursing implications

Use the local central-line risk and escalation pathway, raise concerns early, and continue required insertion and maintenance bundle practices.

Limitations & cautions

Abstract-only summary. This was a single-system, multiyear quality-improvement project without a concurrent control group; multiple interventions and secular changes prevent attribution to any one component.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Pediatric quality & safety (PubMed). Reducing Inpatient Pediatric Central Line-associated Bloodstream Infections by Proactive Risk Assessment and Escalation.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

The Canadian journal of hospital pharmacy (PubMed)Sep 9, 2026Systematic Review

A systematic review and meta-analysis of five placebo-controlled randomized trials found lower mortality with intravenous hydrocortisone among neonates with hypotension, but the evidence base included only 239 patients.

Peds ICUAI summaryReview source

Systematic ReviewResearchMedication SafetyAI summary · original source linked below

The fixed-effect meta-analysis found an odds ratio for all-cause mortality of 0.48 with intravenous hydrocortisone versus placebo (95% CI 0.24 to 0.96), with low statistical heterogeneity. The authors state that larger trials are needed before the finding is considered confirmed.

Key takeaways

Five randomized, placebo-controlled trials with a total of 239 neonates were included.
The pooled mortality estimate favored hydrocortisone, but the confidence interval approached no difference.
The abstract addresses mortality only and does not provide pooled adverse-event or longer-term neurodevelopmental outcomes.

Why this matters on shift

Hydrocortisone may be considered when neonatal hypotension persists despite volume and vasoactive support, but this mortality signal comes from a small evidence base and should not be presented as definitive.

Bedside takeaway

Treat the mortality signal as promising but preliminary, and follow local NICU monitoring and escalation protocols.

Nursing implications

When hydrocortisone is ordered for refractory neonatal hypotension, continue close hemodynamic and medication monitoring and follow the NICU's dosing, glucose, electrolyte, and escalation protocols.

Limitations & cautions

Abstract-only summary. Only five trials and 239 neonates were pooled; the abstract does not report gestational-age subgroups, dosing differences, adverse events, or neurodevelopmental outcomes.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

The Canadian journal of hospital pharmacy (PubMed). Effect of IV Hydrocortisone on Mortality among Neonates with Hypotension: A Systematic Review and Meta-analysis of Randomized, Placebo-Controlled Trials.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

Practice implications

Limitations & cautions

Exact source links

More updates for this clinical area

Diabetes-specific tube-feeding formulas modestly improved glycemic measures

Proactive central-line huddles accompanied a sustained pediatric CLABSI rate decrease

Small neonatal trials suggest hydrocortisone may reduce mortality in refractory hypotension